We investigated the effects of BRAF, SMAD4, and TP53 mutations on colorectal carcinoma progression by using cBioPortal for Cancer Genomics (http://cbioportal.org, accessed on 3 March 2021) [23,24]. This evidence concerns the gene TP53 and colorectal carcinoma.